对于新诊断出患有冷凝素疾病的患者,不断发展的管理算法
Wilma Barcellini1, Bruno Fattizzo1,2
1SC Ematologia, SS Fisiopatologia delle Anemie, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Expert review of hematology
|June 14, 2024
概括
感冒凝聚蛋白疾病 (CAD) 涉及导致红细胞破坏的自身抗体. 虽然rituximab是最前沿的治疗方法,但像 sutimlimab 这样的补充抑制剂为耐火病例提供了新的希望.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 寒冷凝聚素疾病 (CAD) 是一种自身免疫性血液溶解性贫血,其特点是IgM自身抗体在低温下准红细胞.
- 这些自身抗体的补充激活导致血液溶解,主要是肝脏的血管外,有可能引起血管内危机.
研究的目的:
- 审查CAD的诊断标准.
- 讨论当前和新兴的治疗策略来管理CAD.
- 突出针对耐药或复发性疾病患者的新型向疗法.
主要方法:
- 在PubMed和Scopus (2000-2024) 中使用关键词"CAD"和"自身免疫血清性贫血"进行文献搜索.
- 对诊断要求的审查,包括直接库姆斯试验和高位聚氨酸的C3阳性.
- 对已知和新型治疗药物的治疗疗效的分析.
主要成果:
- 利图西马布在50-60%的有症状的CAD患者中有效.
- 补充抑制剂stimlimab在控制血液溶解和改善耐火性病例中的贫血方面显示>80%的有效性.
- 新兴疗法包括补充抑制剂,针对B细胞的药物和组合疗法.
结论:
- 目前的CAD治疗没有标准化,在不耐药/复发人群中存在未满足的需求.
- 补充抑制剂代表了显著的进步,特别是在血液溶解控制方面.
- 未来的管理可能包括针对多个途径的组合疗法,以改善患者的治疗结果.
更多相关视频
10:24Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
Published on: October 5, 2015
12.4K
09:29Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
11.5K
相关概念视频
02:45Blood Transfusion and Agglutination
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:20Rheumatic Heart Disease IV: Nursing Management
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
01:24Nephrotic Syndrome III : Nursing Management
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...